A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese Patients
NCT00239174
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
394
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
SR147778
Sponsor
Sanofi